- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03203096
Magnesium Supplementation in Stress Conditions
June 26, 2017 updated by: Protina Pharmazeutische GmbH
Randomized, Double-blind, Placebo-controlled Intervention Study About the Effects of Magnesium Supplementation Using Nutritional Supplements on the Stress Parameters of Students Preparing for Examination
This study aims to determine how a 6-week magnesium supplementation with 400 mg magnesium from magnesium citrate/magnesium oxide affects stress parameters in students in exam preparation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The examinations are carried out in 70 students in exam preparation (6 weeks before exam).
The target parameters are determined in blood and 24h-urine.
Blood sampling takes place at confinement, after 3 weeks and at the end of the study (week 6).
In addition, heart rate variability is determined.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Martin, Slovakia, 03601
- Biomed Martin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy students in exam preparation
Exclusion Criteria:
- pregnancy
- any chronic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
identically tasting and looking Placebo
|
|
|
Active Comparator: Magnesium
Supplementation with 400 mg Magnesium from Magnesium Citrate / Magnesium Oxide once daily
|
Magnesium citrate / Magnesium oxide
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood sampling
Time Frame: 6 weeks
|
measurement of stress metabolites
|
6 weeks
|
|
24h-urine
Time Frame: 6 weeks
|
measurement of stress metabolites
|
6 weeks
|
|
heart rate variability
Time Frame: 6 weeks
|
measurement of heart rate variability
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2017
Primary Completion (Actual)
June 6, 2017
Study Completion (Actual)
June 6, 2017
Study Registration Dates
First Submitted
June 22, 2017
First Submitted That Met QC Criteria
June 26, 2017
First Posted (Actual)
June 29, 2017
Study Record Updates
Last Update Posted (Actual)
June 29, 2017
Last Update Submitted That Met QC Criteria
June 26, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- StressMag2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Physiology
-
University of ParmaCompleted
-
United States Army Research Institute of Environmental...United States Army Combat Capabilities Development Command Soldier Center; United...CompletedStress PhysiologyUnited States
-
University of OklahomaUniversity of Tulsa; Oklahoma State UniversityRecruitingPain | Discrimination, Racial | Stress PhysiologyUnited States
-
Duvenciler Anadolu LİsesiCompletedBiomarkers | Oxidative Stress | Healthy Young Women | Redox Homeostasis | Sports Physiology | Regular Exercise | Antioxidant DefenseTurkey (Türkiye)
-
University of Southern CaliforniaWashington University School of Medicine; Keck School of Medicine of USCCompleted
-
University of ArkansasActive, not recruitingStress, Emotional | Methamphetamine-dependence | Substance Use Disorders | Stress Physiology | Stress ReactionUnited States
-
Villanova UniversityActive, not recruitingSubstance-Related Disorders | Alcohol-Related Disorders | Stress, Psychological | Relatives | Coping Skills | Stress Physiology | Family MembersUnited States
-
Beth Israel Deaconess Medical CenterBrigham and Women's HospitalCompletedStress | Stress, Psychological | Sleep | Stress Physiology | Slow BreathingUnited States
-
University of CopenhagenRigshospitalet, DenmarkUnknown
-
Brigham and Women's HospitalCompletedPhysiologyUnited States
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States